INGAP-Peptide

DRUG2 trials

Sponsors

Exsulin Corporation

Conditions

Diabetes Mellitus, Insulin-DependentDiabetes Mellitus, Non-Insulin-Dependent

Phase 2

Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

CompletedNCT00071422

Exsulin CorporationDiabetes Mellitus, Non-Insulin-Dependent

Start: 2003-10-31End: 2004-06-30Updated: 2014-07-11

Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes

CompletedNCT00071409

Exsulin CorporationDiabetes Mellitus, Insulin-Dependent

Start: 2003-10-31End: 2004-05-31Updated: 2014-07-11